IO Biotech, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
IO Biotech, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • IO Biotech, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.68M, a 43.7% decline year-over-year.
  • IO Biotech, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.45M, a 21% decline year-over-year.
  • IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $8.06M, a 14.5% increase from 2022.
  • IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.04M, a 293% increase from 2021.
  • IO Biotech, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.79M, a 2698% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.06M +$1.02M +14.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $7.04M +$5.25M +293% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $1.79M +$1.73M +2698% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $64K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.